1
/
of
1
Elabscience
SKU:PKSV030124
Recombinant DENV (type 2, strain New Guinea C) NS1 Protein (His Tag)
Recombinant DENV (type 2, strain New Guinea C) NS1 Protein (His Tag)
Regular price
$855.00 USD
Regular price
Sale price
$855.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant DENV (Type 2, Strain New Guinea C) NS1 Protein (HIS TAG), a cutting-edge product designed to cater to the needs of scientific research and diagnostic applications. This meticulously engineered protein offers a high level of purity and quality, ensuring accurate and reliable results.
The Recombinant DENV NS1 Protein (HIS TAG) is derived from the Type 2 strain of the Dengue virus, specifically the New Guinea C variant. This strain has been carefully selected for its relevance and significance in the field of virology. The inclusion of the HIS TAG allows for easy purification and detection, facilitating streamlined laboratory processes.
Crafted through advanced recombinant DNA technology, this protein exhibits exceptional stability and functionality. Its precise amino acid sequence guarantees optimal performance, enabling researchers to delve into the intricate mechanisms of the Dengue virus with utmost precision and confidence.
This product is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures. Each batch undergoes rigorous testing to ensure consistency and reliability, meeting the highest industry standards. The Recombinant DENV NS1 Protein (HIS TAG) is supplied in a lyophilized form, preserving its integrity and extending its shelf life.
With its broad range of applications, this protein serves as an invaluable tool in various scientific endeavors. It can be utilized in research studies to elucidate the pathogenesis of Dengue virus infection, aiding in the development of effective therapeutic interventions. Additionally, it finds utility in diagnostic assays, enabling the accurate detection and monitoring of Dengue virus infections.
In summary, the Recombinant DENV (Type 2, Strain New Guinea C) NS1 Protein (HIS TAG) is a superior product that combines cutting-edge technology, exceptional quality, and versatility. Its utilization promises to advance scientific understanding and contribute to the development of strategies to combat Dengue virus infections.
The Recombinant DENV NS1 Protein (HIS TAG) is derived from the Type 2 strain of the Dengue virus, specifically the New Guinea C variant. This strain has been carefully selected for its relevance and significance in the field of virology. The inclusion of the HIS TAG allows for easy purification and detection, facilitating streamlined laboratory processes.
Crafted through advanced recombinant DNA technology, this protein exhibits exceptional stability and functionality. Its precise amino acid sequence guarantees optimal performance, enabling researchers to delve into the intricate mechanisms of the Dengue virus with utmost precision and confidence.
This product is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures. Each batch undergoes rigorous testing to ensure consistency and reliability, meeting the highest industry standards. The Recombinant DENV NS1 Protein (HIS TAG) is supplied in a lyophilized form, preserving its integrity and extending its shelf life.
With its broad range of applications, this protein serves as an invaluable tool in various scientific endeavors. It can be utilized in research studies to elucidate the pathogenesis of Dengue virus infection, aiding in the development of effective therapeutic interventions. Additionally, it finds utility in diagnostic assays, enabling the accurate detection and monitoring of Dengue virus infections.
In summary, the Recombinant DENV (Type 2, Strain New Guinea C) NS1 Protein (HIS TAG) is a superior product that combines cutting-edge technology, exceptional quality, and versatility. Its utilization promises to advance scientific understanding and contribute to the development of strategies to combat Dengue virus infections.
Share
